Ferrous Fumarate

Natural health product licensed in Canada

Other names: Fumarate ferreux
Licence holder: Wampole Group L.P.
NPN or DIN-HM: 00031089
Status: Active licence
Licence date: 16 October 2007
Revision date: 10 February 2026
Form: Comprimé
Route of administration: Orale
Application type: DIN de transition

If this product were sold in France

Dose déclarée au-delà d'une limite
Fer: up to 300 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
À vérifier
Fer: up to 300 mg a day according to the dosing instructions published by Health Canada, above the niveau de sécurité from EFSA for adults (40 mg a day). Son dépassement ne permet pas, à lui seul, de caractériser un risque : l'EFSA n'a pas pu fixer de limite supérieure pour ce nutriment. Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
niveau de sécurité. EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Fer Source : Fumarate ferreux	100 mg	300,000 µg

Non-medicinal ingredients

Carmine, Laque d'aluminium bleu FD&C No 2, Poly(alcool vinylique), Cellulose, microcristalline, Acide stéarique, Dioxyde de silicium, Stéarate de magnésium, Dioxyde de titane, Talc, Phosphate de calcium, dibasique, anhydre, Macrogol, Croscarmellose de sodium, Laque d'aluminium FD&C Rouge n° 40

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	minimum: 18 years	1 Comprimé	minimum: 1 Tous les jours ; maximum: 3 Tous les jours

Uses authorised in Canada

A factor in the maintenance of good health. Helps to form red blood cells and helps in their proper function. Helps to prevent iron deficiency. Source of mineral, a factor in the maintenance of good health. Source of mineral, a factor in normal growth and development. Source of mineral to support biological functions which play a key role in the maintenance of good health. Maintains/supports good health. Contributes to maintaining general health. For maintaining general health. A factor in normal growth and development. Mineral supplement. Helps to prevent iron deficiency anaemia. Helps to prevent iron deficiency anemia and associated tiredness and fatigue. Helps pregnant women meet (the) (Health Canada's) recommended intake for iron, when taken in conjunction with a healthy diet.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.